NAV
$55.37
AUM
$288.4M
Expense Ratio
-
Dividend Yield
0.00%
Beta
0.38
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +6.73% | +3.29% | +6.00% | +11.41% | +11.01% | +6.99% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | ASML.AS | ASML Holding NV | 3.59% |
| 2 | AZN.L | AstraZeneca PLC | 2.05% |
| 3 | SIE.DE | Siemens AG | 1.79% |
| 4 | IFX.DE | Infineon Technologies AG | 1.52% |
| 5 | SHEL.L | Shell PLC | 1.51% |
| 6 | HSBA.L | HSBC Holdings PLC | 1.48% |
| 7 | NESN.SW | Nestle SA | 1.42% |
| 8 | ALV.DE | Allianz SE | 1.41% |
| 9 | ROP.SW | Roche Holding AG Ordinary Shares new | 1.33% |
The fund seeks to provide capital appreciation through participation in international equity markets while hedging overall market exposure relative to traditional long-only equity strategies. Under normal circumstances, it invests at least 80% of its assets in equity securities. "Assets" means net assets plus the amount of borrowings for investment purposes. The fund primarily invests in equity securities of foreign companies across all market capitalizations, including foreign subsidiaries of U.S. companies.
Inception Date: 2019-03-15